FTSE Developed Europe UCITS ETF
FTSE Developed Europe UCITS ETF - (EUR) Distributing (VEUR)
Related Documents
About this fund
Fund objectives
- The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE Developed Europe Index (the “Index”).
- The Index is comprised of large and mid-sized company stocks in developed markets in Europe.
- The Fund attempts to: 1. Track the performance of the Index by investing in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in extraordinary market, political or similar conditions.
Fund facts
Share class inception
21 May 2013
Listing date
22 May 2013
Investment structure
Irish UCITS
Share Class Assets'
Total Assets
Risk indicator
Strategy
Index
Asset Class
Equity
Investment method
Physical
Index ticker
TAWNT06E
Benchmark
FTSE Developed Europe Index
Dividend schedule
Quarterly
Tax status
Austria, Germany, Switzerland and United Kingdom reporting
Domicile
Ireland
Legal entity
Vanguard Funds PLC
Investment manager
Global Equity Index Management (GE)
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
As at 31 Aug 2026
Beta
R²
Annualized Tracking Error
1 year
3 years
5 years
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 513 | 495 | 31 Aug 2026 |
| Median market capital | 82.3 B | 82.3 B | 31 Aug 2026 |
| 17.5 x | 17.5 x | 31 Aug 2026 | |
| 2.5 x | 2.5 x | 31 Aug 2026 | |
| 13.9% | 14.0% | 31 Aug 2026 | |
| 10.6% | 10.6% | 31 Aug 2026 | |
| Portfolio turnover rate | -16.5% | — | 30 Jun 2026 |
Market allocation
As at 31 Aug 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United Kingdom | Europe | 22.99% | 22.98% | 0.01% |
| France | Europe | 14.33% | 14.33% | 0.00% |
| Switzerland | Europe | 14.22% | 14.22% | 0.00% |
| Germany | Europe | 13.66% | 13.66% | 0.00% |
| Netherlands | Europe | 8.19% | 8.19% | 0.00% |
| Spain | Europe | 6.28% | 6.28% | 0.00% |
| Italy | Europe | 5.73% | 5.73% | 0.00% |
| Sweden | Europe | 5.11% | 5.11% | 0.00% |
| Denmark | Europe | 2.51% | 2.51% | 0.00% |
| Belgium | Europe | 1.80% | 1.80% | 0.00% |
| Finland | Europe | 1.78% | 1.78% | 0.00% |
| Norway | Europe | 1.04% | 1.04% | 0.00% |
| Poland | Europe | 0.82% | 0.82% | 0.00% |
| Austria | Europe | 0.62% | 0.63% | -0.01% |
| Ireland | Europe | 0.59% | 0.59% | 0.00% |
Holdings details
As at 31 Aug 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 4.29446% | Technology | NL | €339,803,952.60 | 234,057 |
| HSBC Holdings PLC | 2.34523% | Financials | GB | €185,568,780.56 | 10,402,288 |
| Roche Holding AG | 2.02636% | Health Care | CH | €160,337,846.16 | 426,529 |
| Novartis AG | 1.88028% | Health Care | CH | €148,779,116.61 | 1,132,820 |
| Shell PLC | 1.68040% | Energy | GB | €132,963,503.82 | 3,406,138 |
| Nestle SA | 1.65651% | Consumer Staples | CH | €131,072,956.55 | 1,560,694 |
| Siemens AG | 1.60559% | Industrials | DE | €127,044,019.20 | 444,832 |
| AstraZeneca PLC | 1.60539% | Health Care | GB | €127,028,504.92 | 909,218 |
| SAP SE | 1.50593% | Technology | DE | €119,158,825.50 | 624,195 |
| Banco Santander SA | 1.43629% | Financials | ES | €113,648,268.34 | 8,974,121 |
Prices and distribution
Prices
NAV Price (EUR)
€48.25
EURChange
-€0.36-0.75% At closure 08 Oct 2026
Market value (GBP)
£40.96
Change
-£0.30-0.74% At closure 08 Oct 2026
NAV 52-week high
€51.05
At closure 08 Oct 2026
Market value 52-week high
£43.80
At closure 08 Oct 2026
NAV 52-week low
€43.39
At closure 08 Oct 2026
Market value 52-week low
£37.97
At closure 08 Oct 2026
NAV 52-week difference
€7.65
Change
+14.99% At closure 08 Oct 2026
Market value 52-week difference
£5.83
Change
+13.32% At closure 08 Oct 2026
Outstanding shares
96,620,107
At closure 30 Sept 2026
Historical Prices
-
Inception date
21 May 2013
Listing date
22 May 2013
| Date | NAV (EUR) | Market price (GBP) |
|---|---|---|
| 08 Oct 2026 | €48.2486 | £40.9550 |
| 07 Oct 2026 | €48.6111 | £41.2600 |
| 06 Oct 2026 | €49.0949 | £41.6900 |
| 05 Oct 2026 | €48.8609 | £41.5300 |
| 02 Oct 2026 | €48.6795 | £41.5150 |
| 01 Oct 2026 | €48.3086 | £41.2200 |
| 30 Sept 2026 | €48.9269 | £41.9500 |
| 29 Sept 2026 | €49.1747 | £42.2800 |
| 28 Sept 2026 | €49.2208 | £42.2750 |
| 25 Sept 2026 | €49.2220 | £42.4800 |
Distribution history
Distribution frequency
Quarterly
Historical performance 30 Sept 2026
2.71%
| Type | Distribution amount (per unit) | Ex-dividend date | Registration date | Payable date |
|---|---|---|---|---|
| Income | €0.1944 | 17 Sept 2026 | 18 Sept 2026 | 30 Sept 2026 |
| Income | €0.7814 | 18 Jun 2026 | 19 Jun 2026 | 01 Jul 2026 |
| Income | €0.1815 | 19 Mar 2026 | 20 Mar 2026 | 01 Apr 2026 |
| Income | €0.1676 | 18 Dec 2025 | 19 Dec 2025 | 31 Dec 2025 |
| Income | €0.1609 | 18 Sept 2025 | 19 Sept 2025 | 01 Oct 2025 |
| Income | €0.7630 | 19 Jun 2025 | 20 Jun 2025 | 02 Jul 2025 |
| Income | €0.1872 | 20 Mar 2025 | 21 Mar 2025 | 02 Apr 2025 |
| Income | €0.1542 | 12 Dec 2024 | 13 Dec 2024 | 27 Dec 2024 |
| Income | €0.1605 | 12 Sept 2024 | 13 Sept 2024 | 25 Sept 2024 |
| Income | €0.7398 | 13 Jun 2024 | 14 Jun 2024 | 26 Jun 2024 |
Purchase information
Currencies and stock exchanges
Listed currencies: GBP, EUR, CHF, USD, MXN
Base currency:EUR
Exchanges: London Stock Exchange, NYSE Euronext - Amsterdam, SIX Swiss Exchange, Deutsche Boerse, Bolsa Mexicana De Valores, Borsa Italiana S.p.A.